GlaxoSmithKline paid a $3 billion fine after they were found to be marketing drugs for off-label use — like suggesting that a powerful drug such as Advair be used for a lesser illness. Once again, it all comes down to money. Among the evidence in the case is an unbelievable video from a 2001 GSK sales convention, including one product manager who tantalized potential customers by asking, “Who wants to be a millionaire?”
